UNDERWRITING AGREEMENTUnderwriting Agreement • October 17th, 2006 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research • New York
Pharmacopeia Drug Discovery, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and Merriman Curhan Ford & Co. (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of 5,798,784 shares (the “Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”). The respective amounts of the Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to issue to the Underwriters, the warrants referred to in Section 1(c) to purchase up to an aggregate of 1,449,696 shares of Common Stock.
